CBD Life Sciences Inc. — Regulation A 1-A POS

CBD Life Sciences Inc. of Scottsdale, AZ filed a Regulation A 1-A POS with the SEC on 2020-11-17. Aggregate offering: $700K (Tier 1). Industry: Other.

Offering

Filed: 2020-11-17
Form: 1-A POS
Accession: 0001683168-20-003997
Tier: Tier 1
Total aggregate offering: $700K
Issuer portion: $700K
Price per security: $0.0002
Securities offered: Equity (common or preferred stock)
Audit status: Unaudited
Jurisdictions: 4 states/territories

Issuer

CIK: 0001776073
Organized in: NV
Incorporated: 1998
Address: 10953 N. Frank Lloyd Wright Boulevard, Scottsdale, AZ, 85259
Phone: 480-209-1720
Employees: 2 full-time

Financial snapshot (as filed)

Total assets: $137K
Cash & equivalents: $4K
Total liabilities: $150K
Stockholder equity: $-12K
Revenues: $210K
Net income: $-1.5M

People (7)

Name	Role	Location
Eric Newlan	Signer	Irvine, CA
Lisa Nelson	CEO	ALAMEDA, CA
John E. Lux, Esq.	Signer	Miami, FL
Brian Higley, Esq.	Signer	BOCA RATON, FL
Donnell Suares	Signer	FORT LAUDERDALE, FL
Donnell Suares, Esq.	Signer	Scottsdale, AZ
Anthony Michael Panek	Signer	New York, NY

Other Reg A filings by this issuer (25)

Showing 15 of 25 filings.

Filed	Form
2026-05-15	1-A
2025-03-17	1-A POS
2025-03-06	1-A POS
2024-09-06	1-A POS
2024-08-19	1-A POS
2024-06-18	1-A/A
2024-06-05	1-A/A
2024-05-02	1-A
2024-05-01	1-Z
2022-08-18	1-A
2022-08-18	1-Z
2021-06-29	1-A POS
2021-02-05	1-A POS
2021-01-22	1-A POS
2020-11-03	1-A POS

More